Kurt Bruckmeier, MD
Geriatric Medicine · Hattiesburg, MSNPI 1083610117
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $385 of the $445 with a category attached, or 86.5%. 10 manufacturers reported payments, led by AstraZeneca at 25.0% of the total.
Across 25 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$111
- AbbVie$65
- Johnson & Johnson$62
- E.r. Squibb & Sons, L.L.C.$46
- Novartis$37
- Boehringer Ingelheim$36
- plus $87 from 4 others
What the payments were for
- Food & beverage$38587%
- Education$6013%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $111 |
| AbbVie(2 entities) | 4 | $65 |
| Johnson & Johnson | 4 | $62 |
| E.r. Squibb & Sons, L.L.C. | 4 | $46 |
| Novartis | 2 | $37 |
| Boehringer Ingelheim | 2 | $36 |
| Pfizer | 2 | $28 |
| Bioxcel Therapeutics, Inc. | 1 | $21 |
| Vertex | 1 | $19 |
| Merck | 1 | $18 |
How this compares
Too few geriatric medicine providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone Sodium SuccMethylprednisolone Sod Succ | 12 | $459 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 11 | $321 |
| Baclofen | 13 | $268 |
| Methimazole | 12 | $250 |
| Lovastatin | 13 | $242 |
| Pravastatin Sodium | 11 | $228 |
| Tamsulosin Hcl | 13 | $221 |
| Hydrochlorothiazide | 13 | $93 |
| Atorvastatin Calcium | 16 | $81 |
| Levofloxacin | 12 | $44 |
| Sodium Chloride0.9 % Sodium Chloride | 16 | $41 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Hattiesburg
- Rebecca HollingsworthHattiesburg$2K
- Wendell GloverRidgeland$3K
- Russell BelenchiaUnion$712
- Amanda CooleyMagee$455
- Sara ParksJackson$451
- Holland AddisonJackson$387
- Vicky McLeanJackson$386
- Sara SandersJackson$310
- Kimberly Covington TarverJackson$208
- John HeyGreenwood$186
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.